Principal Financial Group
GPCR icon

Principal Financial Group’s Structure Therapeutics GPCR Stock Holding History

Principal Financial Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.1M Sell
1,752,753
-1,011
-0.1% -$44.7K 0.05% 314
2026
Q1 		$84.5M Buy
1,753,764
+469,554
+37% +$32.1M 0.05% 329
2025
Q4 		$89.3M Buy
1,284,210
+496,726
+63% +$20.3M 0.05% 304
2025
Q3 		$22M Sell
787,484
-65,718
-8% -$1.31M 0.01% 813
2025
Q2 		$17.7M Buy
853,202
+96,495
+13% +$2.12M 0.01% 903
2025
Q1 		$13.1M Sell
756,707
-34,427
-4% -$843K 0.01% 1111
2024
Q4 		$21.5M Buy
791,134
+245,775
+45% +$8.72M 0.01% 818
2024
Q3 		$23.9M Buy
545,359
+380,115
+230% +$14.7M 0.01% 748
2024
Q2 		$6.49M Buy
+165,244
New +$6.79M ﹤0.01% 1463

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Principal Financial Group's GPCR Position: Q2 2026 in Review

Principal Financial Group reduced its Structure Therapeutics (GPCR) stake by 0.06% in Q2 2026, selling an estimated $44.7K and leaving 1,752,753 shares worth $94.1M. The position accounts for 0.05% of the portfolio, ranked #314.

Principal Financial Group first reported a position in GPCR in Q2 2024 and has held it in 9 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Principal Financial Group held 1,752,753 shares of Structure Therapeutics worth $94.1M as of Q2 2026.
  • Principal Financial Group sold 1,011 Structure Therapeutics shares in Q2 2026, an estimated $44.7K.
  • Structure Therapeutics made up 0.05% of Principal Financial Group's portfolio in Q2 2026, its #314 holding.
  • Principal Financial Group first reported a position in Structure Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.